Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis

Medicine and Dentistry

• Scleroderma 100%
• C Reactive Protein 50%
• Disease Exacerbation 50%
• Muscle Weakness 50%
• Pulmonary Fibrosis 50%
• Finger Ulcer 50%
• Echocardiography 25%
• Lung 25%
• Predictive Factor 25%
• Heart Function 25%

Immunology and Microbiology

• Systemic Scleroderma 100%
• C-Reactive Protein 50%
• Muscle 50%
• Heart Function 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Systemic Sclerosis 100%
• Muscle Weakness 50%
• Lung Fibrosis 50%